WHO Approves World’s First Mpox Vaccine: A Breakthrough for High-Risk Communities

Date:

The World Health Organization (WHO) has announced that the MVA-BN vaccine is now officially prequalified as the first vaccine for mpox. This major step is expected to increase access to the vaccine, especially in areas where it is needed most during mpox outbreaks.

The prequalification, based on data from the vaccine manufacturer Bavarian Nordic A/S and reviewed by the European Medicines Agency, is designed to speed up the distribution of the vaccine to countries that need it.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted the significance of this approval in managing mpox outbreaks, particularly in African nations. He urged a quick and efficient rollout of the vaccine to ensure that those at high risk get access. “This vaccine, along with other public health measures, will help reduce infections, stop the spread, and save lives,” he said.

Related Article – Mpox Makes its entry into India! First case reported

The MVA-BN vaccine is given in two doses, four weeks apart, and is currently approved for use in people over 18. The vaccine can be stored at 2 to 8 degrees Celsius for up to eight weeks, making it easier for regions with limited cold storage options to maintain supplies.

Dr. Yukiko Nakatani, WHO’s Assistant Director-General for Access to Medicines and Health Products, noted that the approval will help global organizations like Gavi and Unicef quickly procure and distribute the vaccine. This will be crucial for frontline communities, particularly in Africa where mpox cases are more prevalent.

Data shows that a single dose of the MVA-BN vaccine is about 76% effective in preventing mpox, with two doses increasing protection to around 82%.

This approval marks a significant milestone in the fight against mpox, ensuring faster access to life-saving vaccines in high-risk areas.

Looking for reliable news updates? Visit StorifyNews.com, a trusted platform for the latest in global health, technology, and more!

Related Article: What is the Mpox Clade 1b Variant?

Exciting news! Storify News is now on WhatsApp Channels. Subscribe today by clicking the link and stay updated with the latest news! Click here!

Suhina Bisaria
Suhina Bisariahttps://www.storifynews.com/
Suhina Bisaria is a journalist with a marketing degree. She is keen to learn and write about everything people might be interested in. She has worked as a copy editor in Delhi with prestigious news organisations. Apart from keeping track of all things newsworthy and delivering error-free content to users, she has also tried her hand at writing human interest features, celebrities Net worth researcher, health and lifestyle stories, education, Bio creator and viral news.

Share post:

Subscribe US

New York
clear sky
22 ° C
22 °
22 °
38%
3.9m/s
1%
Fri
22 °
Sat
21 °
Sun
17 °
Mon
22 °
Tue
25 °

Popular

More like this
Related

Which Antibacterial Period Pads Are Best for Travel?

Nobody packs for a trip expecting to spend it...

How much financial support is provided to TB patients under the ni-kshay poshan yojana?

Under the Ni-kshay Poshan Yojana (NPY)—a Direct Benefit Transfer (DBT)...

Maharashtra FDA Crackdown Under Tukaram Mundhe Puts Food Safety and Public Health Under the Spotlight

Tukaram Mundhe, the Maharashtra FDA Commissioner, is currently taking...

India Plans New Health Insurance Rules to Reduce Healthcare Costs

Indian government is now planning to create a new...